What is NAD+?
NAD+ (nicotinamide adenine dinucleotide) is not a peptide — it's a coenzyme present in every living cell, as fundamental to biology as ATP. Every cell requires NAD+ to convert food into energy, repair damaged DNA, regulate circadian rhythms, and maintain the sirtuins — a family of proteins that control cellular stress responses and longevity-related gene expression. NAD+ is the molecule that makes most of what keeps cells alive possible.
The longevity angle is straightforward: NAD+ levels decline approximately 50% between ages 20 and 60. This decline tracks closely with the hallmarks of aging across tissues. Lower NAD+ means less efficient mitochondria, less DNA repair capacity, reduced sirtuin activity, and impaired cellular stress responses. In animal models, restoring NAD+ levels reverses many of these age-related declines — improving muscle function, metabolic health, cognitive performance, and in some models, extending lifespan.
The practical question is how to elevate NAD+. Direct NAD+ doesn't survive oral administration well — it's broken down in the gut. The practical approaches are: NMN (nicotinamide mononucleotide) or NR (nicotinamide riboside) as oral precursors; IV NAD+ infusions for acute high-dose elevation; or subcutaneous NMN injection. The relative effectiveness of different precursors and routes is an active research question with real clinical data emerging.
The honest evidence picture: the preclinical case for NAD+ in aging is among the strongest in all of longevity biology. The human clinical evidence is earlier-stage — multiple trials confirming that oral NMN and NR do elevate blood and tissue NAD+ levels, and a growing number of trials showing improvements in specific outcomes — but the landmark human longevity trial doesn't exist yet. The mechanism is real and compelling; the human clinical validation is catching up.
How it works
NAD+ in Energy Metabolism
NAD+ is a coenzyme in glycolysis, the citric acid cycle, and oxidative phosphorylation — the three core processes cells use to produce ATP from nutrients. In each pathway, NAD+ accepts electrons (becoming NADH) and then donates them to the electron transport chain in mitochondria to produce ATP. Without adequate NAD+, cellular energy production is impaired. This is why mitochondrial dysfunction and NAD+ decline are closely linked in aging tissue.
Sirtuin Activation
Sirtuins (SIRT1–SIRT7) are NAD+-dependent deacetylases that regulate gene expression, DNA repair, mitochondrial biogenesis, and inflammation in response to metabolic state. They require NAD+ as a substrate to function. When NAD+ falls with age, sirtuin activity falls proportionally. Restoring NAD+ reactivates sirtuin function — SIRT1 (metabolic regulation, stress resistance), SIRT3 (mitochondrial function), and SIRT6 (DNA repair, telomere maintenance). This is the primary mechanistic bridge between NAD+ and longevity.
PARP Activation and the NAD+ Depletion Cycle
PARPs (poly ADP-ribose polymerases) are DNA damage sensors that consume NAD+ as a substrate. Every DNA repair event costs NAD+. As DNA damage accumulates with age and oxidative stress increases, PARP activation ramps up and NAD+ is increasingly consumed by repair — accelerating the NAD+ decline. This creates a vicious cycle: more damage → more PARP activity → less NAD+ → less sirtuin activity → less DNA repair → more damage.
Precursor Pathways
NAD+ is synthesized from multiple precursors: NMN → NAD+ via NMNAT enzymes. NR → NMN → NAD+. Niacin → NAD+ via the Preiss-Handler pathway (causes flushing). Niacinamide → NAD+ but also inhibits sirtuins at high concentrations. NMN and NR are the preferred precursors because they efficiently enter the NAD+ biosynthesis pathway without the sirtuin-inhibiting effects of niacinamide.
What the research shows
Effect of oral nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men
Irie J, Inagaki E, Fujita M et al.
10 healthy Japanese men given single oral NMN doses (100, 250, 500 mg) with 5-hour monitoring. NMN was safe — no problematic changes in vitals, labs, ophthalmology or sleep — and its metabolites (N-methyl-2-pyridone- and 4-pyridone-5-carboxamide) rose dose-dependently, an early human confirmation that oral NMN is absorbed and metabolized. A single-dose safety/bioavailability study, not a long-term performance trial.
View on PubMed →Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell SAJ, Schmidt MS, Weidemann BJ et al.
12 healthy adults given single oral NR doses (100, 300, 1000 mg). Dose-dependent increases in the blood NAD+ metabolome — a single dose raised NAD+ up to ~2.7-fold. The first human pharmacokinetic trial establishing that oral NR reliably boosts NAD+.
View on PubMed →Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Yoshino M, Yoshino J, Kayser BD et al.
Randomized, double-blind, placebo-controlled trial in 25 postmenopausal women (overweight/obese) with prediabetes. NMN 250 mg/day for 10 weeks significantly increased insulin-stimulated muscle glucose disposal and shifted muscle-remodeling gene expression, without changing body weight. Human proof that NMN can improve muscle insulin sensitivity.
View on PubMed →The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults — a randomized, dose-dependent clinical trial
Yi L, Maier AB, Tao R et al.
80 healthy middle-aged adults, randomized to placebo or 300, 600, or 900 mg NMN daily for 60 days. Safe and well-tolerated at every dose, with significant dose-dependent NAD+ elevation and improved six-minute-walk distance versus placebo; 600 mg gave the best balance. Solid human evidence that sustained NMN both raises NAD+ and moves a physical-function needle.
View on PubMed →What the community reports
NAD+ has the most mainstream-adjacent community of any compound in the longevity space — bridging the peptide biohacker audience and the broader wellness/anti-aging world. The community spans people taking oral NMN or NR daily, people doing periodic IV NAD+ infusions at longevity clinics, and hardcore biohackers doing subcutaneous NMN injections. Reports vary significantly by route and dose.
Common misconceptions
"NAD+ is proven to extend human lifespan."
NAD+ extends lifespan in multiple animal models. Human lifespan trials don't exist and wouldn't be practical to run. The human evidence is for biomarkers and intermediate outcomes — NAD+ elevation, muscle function, insulin sensitivity — not longevity itself. The longevity extrapolation is based on animal models and mechanistic reasoning.
"Oral NAD+ supplementation works the same as precursors."
Oral NAD+ is largely broken down in the gut before absorption. Precursors (NMN, NR) survive gut transit, enter cells, and are converted to NAD+ intracellularly. IV NAD+ bypasses this — it's delivered directly to blood. If you're buying 'NAD+ capsules' that aren't NMN or NR, you're likely not getting meaningful NAD+ elevation.
"More is always better with NAD+."
Niacinamide (nicotinamide) — one NAD+ precursor — inhibits sirtuins at high concentrations, which would counteract the sirtuin-activation benefit of elevated NAD+. High-dose niacinamide is actively counterproductive for longevity goals. NMN and NR don't have this concern at typical doses, but the 'more is better' logic still doesn't hold indefinitely.
"IV NAD+ is dramatically superior to oral for longevity."
IV NAD+ produces rapid, acute NAD+ elevation with immediately noticeable effects. Whether this translates to meaningfully better long-term outcomes than consistent oral NMN or NR is not established. IV infusions cost $300–$800 per session; consistent oral NMN costs $50–$100/month. The cost-benefit calculation depends on what you're optimizing for.
LONGEVITY STACK
NAD+ is commonly combined with Epithalon (telomere maintenance via pineal peptide) for a comprehensive longevity stack targeting different aging mechanisms simultaneously.
Open PepperLedger to log your NAD+ protocol →
Free to join. No credit card. Ask the Researcher about your NAD+ protocol once you're in.
Free to join · No credit card · 23-day Pro trial included
Registered trials and extra catalog links. These are not Study cards — a registry page is not proof of efficacy.
- ClinicalTrials.gov · completed · NCT07336836Oral nicotinamide adenine dinucleotide (NAD+) vs placebo